Mr. Speaker, before I answer the question, let me say that, having had the opportunity to discuss some issues relating to medical assistance in dying with the hon. member, I was moved by some of his perspectives he shared with me personally and in public as well.
These are complex issues, but it is not as though they have not been studied at length. We have seen Parliament debate these issues in 2016 and 2021. We have seen special committees study these issues in 2023, as well as the Department of Health in 2025.
One of the things that I have taken from my own engagement is that there are very real people who are suffering today as a result of the lack of access to a regime that pertains to advance directives. They are people who do not have the choice or the agency because of the certainty with which they are going to lose capacity.
In addition, the reasons we would normally have to divide a bill do not exist given the fact that there are multiple experts who can testify to both of these issues. I hope to address more in follow-up questions.
